Weight Management in Nonalcoholic Steatohepatitis
Anti-Fibrotic Effects of Losartan In Nash Evaluation Study
Development of a Breath Test for Monitoring Patients With Liver Disease
|4||Not yet recruiting||
The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes
A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis
Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
† Study has passed its completion date and status has not been verified in more than two years.